| # | Country | Total Patents | |
|---|---|---|---|
| #1 | Canada | 2 | |
| #2 | China | 2 | |
| #3 | EPO (European Patent Office) | 2 | |
| #4 | Republic of Korea | 2 | |
| #5 | Mexico | 2 | |
| #6 | United States | 2 | |
| #7 | WIPO (World Intellectual Property Organization) | 2 | |
| #8 | Hong Kong | 1 | |
| #9 | South Africa | 1 |
| # | Industry | |
|---|---|---|
| #1 | Pharmaceuticals | |
| #2 | Organic fine chemistry |
| # | Technology | |
|---|---|---|
| #1 | Therapeutic chemical compounds | |
| #2 | Medical preparations | |
| #3 | Heterocyclic compounds | |
| #4 | Acyclic or carbocyclic compounds |
| # | Name | Total Patents |
|---|---|---|
| #1 | Wesser Tim | 13 |
| #2 | Fischer Robert | 13 |
| #3 | Konkel Anne | 13 |
| #4 | Westphal Christina | 7 |
| #5 | Westphal Philipp | 7 |
| #6 | Lossie Janine | 6 |
| #7 | Falck John Russel | 6 |
| #8 | Schunk Wolf-Hagen | 5 |
| #9 | Schunck Wolf-Hagen | 5 |
| #10 | Robert Fischer | 3 |
| Publication | Filing date | Title |
|---|---|---|
| EP3435993A1 | Analogs of cyp-eicosanoids for use in treating or preventing a disorder associated with neovascularization and/or inflammation | |
| CN109562083A | For treating or preventing the CYP- quasi-eicosane acid-like substance with neovascularization and/or inflammation related disease | |
| CN108349880A | The steady analog of CYP eicosanoid metabolics for treating heart disease |